Hammersmith Road
London, England

A thorough analysis of the new ICH pre-clinical safety guidelines – how will these influence the registration and execution of Phase I trials? presented by David Jones, Principal Scientific Officer, Medicines and Healthcare Products Regulatory Agency, MHRA

Official Website: http://www.iir-events.com/IIR-conf/LifeSciences/EventView.aspx?EventID=2005

Added by mBLAST on September 28, 2008

Interested 1